CaffeenHeadache™️ Profile picture
Jophas (Joe for short) from the WI part of MI

May 7, 10 tweets

đź§µAnother continuing thread branch

1/ 2021 PLOS Pathogens (Henan Univ + Western Univ of Health Sciences + Univ Kansas Med Ctr): hantaviruses use host factor **P58IPK** to counter PKR defenses. (1)

2/ China has a growing “CRISPR + hantavirus” literature—but it’s mainly **diagnostics**:

CRISPR-Cas systems used to detect hantavirus RNA quickly/sensitively.

Useful for surveillance, but it’s not editing the virus genome. Example: 2025 J Med Virol CRISPR/Cas12a work. (2)

3/ **Reverse genetics** is closest to “editing hantavirus”:

Recover virus from cloned genome segments. Milestone: “Rescue of Hantaan virus minigenomes” (2003). A 2023 JID review notes the field long lacked full-length clone systems—so true genome-editing papers are scarce. (3)(4)

5/ We are giving you the breadcrumbs in hopes of experts connecting the dots with their extensive relevant knowledge and credibility.

We looked for hantavirus + CRISPR work with American and Chinese scientists since 1993.

The strongest public match is not edited hantavirus — it is CRISPR editing of host genes / animal models to study how hantavirus enters cells.

6/ The key 2018 Nature paper identified PCDH1 as an entry factor for Andes & Sin Nombre hantaviruses.

U.S. labs included Einstein, USAMRIID, and Utah State; Chinese-born USU scientist Zhongde Wang co-led the work, with Rong Li in the Wang lab.

7/ The CRISPR piece was on the host side:

USU says its team used CRISPR/Cas9 to create the first PCDH1-knockout hamster model. Removing that receptor made hamsters largely resistant to Andes virus lung injury.

8/ A 2023 follow-up pushed further: researchers used CRISPR/Cas9 genome engineering to introduce two PCDH1 mutations in hamsters, mapping a receptor surface used by hantavirus glycoproteins.

Still: host receptor editing, not editing hantavirus itself.

9/ Citations:
2018 Nature PCDH1 paper: nature.com/articles/s4158…
USU CRISPR/hamster summary: usu.edu/today/story/st…
Zhongde Wang bio: usu.edu/today/story/fr…
2023 Nat Comm follow-up: nature.com/articles/s4146…
eLife CRISPR receptor-depletion near-miss: elifesciences.org/articles/69708
China-only CRISPR diagnostic example: sciencedirect.com/science/articl…

@threadreaderapp unroll please

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling